Hepatitis B: From control to cure
Journal
Journal of the Formosan Medical Association
Journal Volume
117
Journal Issue
10
Pages
868-870
Date Issued
2018
Author(s)
SDGs
Other Subjects
adefovir dipivoxil; alpha2b interferon; antivirus agent; entecavir; hepatitis B antibody; hepatitis B core antigen; hepatitis B surface antigen; hepatitis B vaccine; interferon; lamivudine; nucleoside analog; nucleotide derivative; peginterferon alpha2a; telbivudine; tenofovir alafenamide; tenofovir disoproxil; antivirus agent; antiviral therapy; chronic hepatitis B; cytotoxic T lymphocyte; decompensated liver cirrhosis; disease exacerbation; human; immunoprophylaxis; infection control; liver cell; liver cirrhosis; liver disease; Short Survey; treatment outcome; chronic hepatitis B; disease management; drug effect; Hepatitis B virus; vaccination; Antiviral Agents; Disease Management; Hepatitis B virus; Hepatitis B, Chronic; Humans; Vaccination
Publisher
Elsevier B.V.
Type
short survey